Direxion Daily S&P Biotech Bull 3x Shares Rating $47.00 +1.53 (+3.36%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$46.78 -0.22 (-0.47%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.76Holdings in LABU have an aggregate rating of Moderate Buy based on 650 analyst ratings issued in the past year covering 39 companies (47.1% of the portfolio).LABU Aggregate Price Target$47.00High Prediction$47.00Average Prediction$47.00Low Prediction$47.00Holdings in LABU have an aggregate price target of $47.00 and a range of $47.00 to $47.00 covering 39 companies (47.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.88%ALNYAlnylam Pharmaceuticals$234.56+1.8%4.6223 of 5 stars2.77$315.58 34.5%26Analyst RevisionPositive News1.78%INSMInsmed$72.53+3.3%4.1733 of 5 stars3.00$94.00 29.6%16Insider TradeNews CoveragePositive News1.76%NBIXNeurocrine Biosciences$101.38+1.3%4.829 of 5 stars2.91$161.86 59.7%23Analyst UpgradeAnalyst Revision1.69%NTRANatera$148.08-1.4%3.0023 of 5 stars3.00$175.76 18.7%16Positive News1.69%UTHRUnited Therapeutics$284.73-0.2%4.9027 of 5 stars2.67$388.25 36.4%12Analyst UpgradeInsider TradePositive News1.68%VRTXVertex Pharmaceuticals$489.10+0.7%4.108 of 5 stars2.64$512.41 4.8%25Short Interest ↓Positive News1.67%BIIBBiogen$118.61+2.9%4.7269 of 5 stars2.42$213.15 79.7%31Upcoming EarningsAnalyst ForecastAnalyst Revision1.66%AMGNAmgen$277.29-1.9%4.6012 of 5 stars2.48$314.91 13.6%23Analyst DowngradeAnalyst Revision1.66%GILDGilead Sciences$104.49-0.4%4.5365 of 5 stars2.72$105.12 0.6%29Upcoming EarningsInsider TradePositive News1.64%ABBVAbbVie$172.78+0.6%4.9005 of 5 stars2.85$210.71 22.0%26Upcoming EarningsEx-DividendAnalyst ForecastAnalyst RevisionPositive News1.60%EXASExact Sciences$41.58-1.6%4.2288 of 5 stars2.95$69.25 66.5%22Positive News1.57%REGNRegeneron Pharmaceuticals$563.16+2.5%4.8456 of 5 stars2.77$963.56 71.1%26Analyst ForecastNews CoveragePositive News1.54%MDGLMadrigal Pharmaceuticals$301.66-2.0%4.4451 of 5 stars2.80$378.44 25.5%10News CoveragePositive NewsGap Up1.52%INCYIncyte$58.21+0.8%4.8673 of 5 stars2.21$74.88 28.6%19Analyst RevisionPositive News1.51%MRNAModerna$24.72-1.9%4.244 of 5 stars2.04$58.70 137.5%24Analyst ForecastAnalyst Revision1.47%BMRNBioMarin Pharmaceutical$59.17+0.6%4.9062 of 5 stars2.71$94.00 58.9%24Upcoming EarningsAnalyst DowngradeAnalyst Revision1.43%PCVXVaxcyte$30.65+5.3%3.2903 of 5 stars3.10$136.50 345.4%10Positive News1.38%BPMCBlueprint Medicines$84.62+3.1%2.6252 of 5 stars2.70$124.95 47.7%23Analyst ForecastAnalyst RevisionNews Coverage1.32%EXELExelixis$36.19+0.1%4.255 of 5 stars2.50$37.59 3.9%20Analyst ForecastPositive News1.14%TGTXTG Therapeutics$38.32+0.3%3.3689 of 5 stars2.83$40.67 6.1%6Positive News1.11%BBIOBridgeBio Pharma$33.87+0.1%4.5946 of 5 stars2.92$53.00 56.5%12Analyst ForecastInsider TradeAnalyst RevisionNews Coverage1.11%HALOHalozyme Therapeutics$58.79-0.1%4.3509 of 5 stars2.60$62.78 6.8%10Positive News1.08%SRPTSarepta Therapeutics$53.79-0.3%4.6732 of 5 stars2.83$161.83 200.8%24Gap Down1.00%CYTKCytokinetics$39.48+0.8%3.7767 of 5 stars2.94$81.63 106.8%18Analyst ForecastInsider TradeNews Coverage0.96%RVMDRevolution Medicines$36.76+1.5%3.7466 of 5 stars3.00$66.67 81.4%12Positive News0.86%IONSIonis Pharmaceuticals$28.40+0.2%4.0369 of 5 stars2.70$56.72 99.7%20Analyst ForecastAnalyst Revision0.85%CRSPCRISPR Therapeutics$37.770.0%3.0291 of 5 stars2.48$73.11 93.6%21Analyst Revision0.82%SWTXSpringWorks Therapeutics$37.89+0.4%2.2326 of 5 stars3.00$73.20 93.2%5Options VolumeNews Coverage0.81%ROIVRoivant Sciences$10.15+1.3%2.5472 of 5 stars3.00$17.50 72.4%4Positive NewsGap Up0.78%ALKSAlkermes$27.05-0.5%4.6533 of 5 stars2.67$38.50 42.3%12Short Interest ↓Analyst Revision0.74%VKTXViking Therapeutics$23.94+1.4%4.3554 of 5 stars2.92$89.75 274.9%13Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageGap Down0.73%SMMTSummit Therapeutics$24.61+6.8%2.7997 of 5 stars3.00$35.40 43.8%100.72%RNAAvidity Biosciences$26.66+3.5%2.1649 of 5 stars3.00$66.69 150.2%13Positive NewsGap Up0.71%ADMAADMA Biologics$21.31+0.4%1.924 of 5 stars3.25$22.50 5.6%4Options VolumeNews CoveragePositive News0.70%KRYSKrystal Biotech$168.57+2.3%4.7124 of 5 stars3.00$220.00 30.5%8Positive News0.69%APLSApellis Pharmaceuticals$18.20+0.2%4.1324 of 5 stars2.63$45.59 150.5%19Analyst RevisionNews CoveragePositive News0.63%TWSTTwist Bioscience$36.80-4.3%3.6221 of 5 stars2.70$52.80 43.5%10Positive News0.62%ACLXArcellx$62.02+2.2%2.0614 of 5 stars3.14$110.67 78.4%14Positive News0.59%NUVLNuvalent$71.64+2.4%1.7599 of 5 stars2.90$115.50 61.2%10Insider TradeNews CoveragePositive News This page (NYSEARCA:LABU) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABU Stock Free LABU Stock Alerts